Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma Group (MREO) Gross Profit: 2017-2024

Historic Gross Profit for Mereo BioPharma Group (MREO) over the last 8 years, with Dec 2024 value amounting to -$1.4 million.

  • Mereo BioPharma Group's Gross Profit rose 177.05% to $272,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$307,000, marking a year-over-year decrease of 210.04%. This contributed to the annual value of -$1.4 million for FY2024, which is 118.45% down from last year.
  • As of FY2024, Mereo BioPharma Group's Gross Profit stood at -$1.4 million, which was down 118.45% from $7.4 million recorded in FY2023.
  • In the past 5 years, Mereo BioPharma Group's Gross Profit registered a high of $25.0 million during FY2021, and its lowest value of -$9.8 million during FY2020.
  • Over the past 3 years, Mereo BioPharma Group's median Gross Profit value was -$1.4 million (recorded in 2024), while the average stood at $627,000.
  • In the last 5 years, Mereo BioPharma Group's Gross Profit soared by 356.33% in 2021 and then slumped by 118.45% in 2024.
  • Yearly analysis of 5 years shows Mereo BioPharma Group's Gross Profit stood at -$9.8 million in 2020, then spiked by 356.33% to $25.0 million in 2021, then tumbled by 116.69% to -$4.2 million in 2022, then skyrocketed by 277.87% to $7.4 million in 2023, then crashed by 118.45% to -$1.4 million in 2024.